Press Release History - 2018

  • 6 Apr 2018
    ThromboGenics announces publication in The Journal of Medicinal Chemistry of preclinical data supporting therapeutic potential of THR-149
  • 4 Apr 2018
    ThromboGenics Reports Initial Data from its Clinical Study evaluating THR-317 for the Treatment of Diabetic Macular Edema (DME)
  • 15 Mar 2018
    ThromboGenics Business Update – FY 2017
  • 30 Jan 2018
    Disclosure in accordance with Belgian Law of 2 May 2007
  • 26 Jan 2018
    NOVARTIS PHARMA AG HOLDING 5.69% OF THROMBOGENICS EQUITY CAPITAL